TRex BioFinal pricing
TRex Bio prices its IPO
TRex Bio prices its IPO (October 8, 2026).
TRex Bio is a clinical-stage biopharmaceutical company developing immunoregulatory medicines based on tissue Treg biology.
Offering details
- Offer price
- $14.0
- Shares offered
- 8.3M
- Exchange
- Nasdaq Global Select Market
- Proposed ticker
- TRXB
- Offering size
- $116.7M
Changes to the terms
| Metric | Previously disclosed (2026-10-05) | This announcement (2026-10-08) |
|---|---|---|
| Offer price | $14.0 to $16.0 | $14.0 |
Updates
Added: Company description, Currency, Exchange, Offer price, Offering size, Earlier announcement
Company description: TRex Bio is a clinical-stage biopharmaceutical company developing immunoregulatory medicines based on tissue Treg biology.
Currency: USD
Exchange: Nasdaq Global Select Market
Offer price: $14.00
Offering size: $116,666,676.00
Linked the preceding announcement for this offering so readers can follow its development.